Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1 and Thymosin for Severe COVID-19 Pneumonia
NCT04268537Phase 2Unknown
- Sponsor
- Southeast University
- Start
- Feb 2020
- Primary completion
- Apr 2020
01
Overview
Phase 2, randomised, open-label trial in COVID-19 pneumonia (3 arms), sponsored by Southeast University. Primary endpoint: Lung injury score at 7 days. Status: unknown.
02
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04268537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04268537.